Skip to main content
NVDA+1.10%AAPL-0.10%GOOGL+0.86%MSFT+0.85%AMZN+0.80%TSM+2.75%SPCX+7.63%META+0.23%AVGO+2.08%TSLA+0.82%SKHY-0.06%MU+0.34%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.46%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.15%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.97%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.91%USDZAR-0.78%USDMXN-0.78%USDPLN-0.74%AUDCHF+0.73%AUDJPY+0.64%CHFSEK-0.57%USDSEK-0.53%GBPCHF+0.51%NZDMXN-0.50%GBPJPY+0.45%NOKJPY+0.44%GBPTRY+0.41%GBPZAR-0.41%EURZAR-0.40%EURHKD+0.39%USDDKK-0.37%EURCHF+0.36%AUDCAD+0.36%AUDUSD+0.36%EURPLN-0.35%AUDNZD+0.34%EURCNH+0.33%GBPHKD+0.32%NZDCHF+0.30%SGDJPY+0.30%CHFNOK-0.30%EURJPY+0.29%USDCHF+0.29%GBPMXN-0.28%CADCHF+0.27%EURAUD-0.27%USDNOK-0.27%GBPCAD+0.25%NZDJPY+0.25%EURSGD+0.24%AUDDKK-0.24%GBPUSD+0.24%USDJPY+0.24%GBPSGD+0.23%GBPNZD+0.22%CADJPY+0.21%EURCZK-0.20%CHFSGD-0.17%USDILS+0.16%GBPAUD-0.16%EURSEK-0.15%NZDSGD+0.15%EURGBP-0.14%AUDNOK-0.14%USDSGD-0.13%USDTHB+0.13%EURNOK+0.11%USDTRY+0.10%EURCAD+0.10%EURUSD+0.09%EURNZD+0.08%CHFJPY-0.07%USDCNH-0.04%USDCOP-0.04%NZDCAD+0.04%USDCAD+0.02%NZDUSD+0.02%EURDKK+0.01%USDHKD+0.01%AUDSGD-0.01%UKOIL-2.72%COCOA-2.28%USOIL-2.21%W1+1.16%C1+0.98%XPTUSD-0.88%GAUUSD+0.84%XAUUSD+0.84%S1+0.64%GAGUSD+0.42%XAGUSD+0.42%COTTON+0.39%BTCUSD+0.43%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.24%ZECUSDT+2.16%DOGEUSD-1.82%XMRUSDT-0.80%LINKUSD+3.21%XLMUSD+0.17%BCHUSDT-0.09%UNIUSD-2.58%LTCUSD-4.60%SUIUSD-1.29%HBARUSDT-0.71%TONUSD+12.52%TAOUSDT-1.17%AAVEUSD-1.24%DOTUSDT-0.94%ICPUSDT-4.04%ONDOUSDT-0.58%WLDUSDT+1.18%ARBUSDT-3.45%JUPUSDT-1.29%ATOMUSDT-0.75%INJUSDT+1.78%STXUSDT-0.18%FETUSDT-2.25%SEIUSDT-0.61%PYTHUSDT+0.86%TIAUSDT-0.59%IMXUSDT-2.28%GRTUSDT-1.04%OPUSDT-3.71%IOTAUSDT+3.66%WIFUSDT-0.40%AXSUSDT-1.32%POLUSDT-0.29%FARTCOINUSDT+1.82%EOSUSDT+4.13%DYDXUSDT-2.25%GALAUSDT-0.52%ORDIUSDT+1.95%RONINUSDT+2.94%NOTUSDT+1.29%NVDA+1.10%AAPL-0.10%GOOGL+0.86%MSFT+0.85%AMZN+0.80%TSM+2.75%SPCX+7.63%META+0.23%AVGO+2.08%TSLA+0.82%SKHY-0.06%MU+0.34%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.46%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.15%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.97%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.91%USDZAR-0.78%USDMXN-0.78%USDPLN-0.74%AUDCHF+0.73%AUDJPY+0.64%CHFSEK-0.57%USDSEK-0.53%GBPCHF+0.51%NZDMXN-0.50%GBPJPY+0.45%NOKJPY+0.44%GBPTRY+0.41%GBPZAR-0.41%EURZAR-0.40%EURHKD+0.39%USDDKK-0.37%EURCHF+0.36%AUDCAD+0.36%AUDUSD+0.36%EURPLN-0.35%AUDNZD+0.34%EURCNH+0.33%GBPHKD+0.32%NZDCHF+0.30%SGDJPY+0.30%CHFNOK-0.30%EURJPY+0.29%USDCHF+0.29%GBPMXN-0.28%CADCHF+0.27%EURAUD-0.27%USDNOK-0.27%GBPCAD+0.25%NZDJPY+0.25%EURSGD+0.24%AUDDKK-0.24%GBPUSD+0.24%USDJPY+0.24%GBPSGD+0.23%GBPNZD+0.22%CADJPY+0.21%EURCZK-0.20%CHFSGD-0.17%USDILS+0.16%GBPAUD-0.16%EURSEK-0.15%NZDSGD+0.15%EURGBP-0.14%AUDNOK-0.14%USDSGD-0.13%USDTHB+0.13%EURNOK+0.11%USDTRY+0.10%EURCAD+0.10%EURUSD+0.09%EURNZD+0.08%CHFJPY-0.07%USDCNH-0.04%USDCOP-0.04%NZDCAD+0.04%USDCAD+0.02%NZDUSD+0.02%EURDKK+0.01%USDHKD+0.01%AUDSGD-0.01%UKOIL-2.72%COCOA-2.28%USOIL-2.21%W1+1.16%C1+0.98%XPTUSD-0.88%GAUUSD+0.84%XAUUSD+0.84%S1+0.64%GAGUSD+0.42%XAGUSD+0.42%COTTON+0.39%BTCUSD+0.43%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.24%ZECUSDT+2.16%DOGEUSD-1.82%XMRUSDT-0.80%LINKUSD+3.21%XLMUSD+0.17%BCHUSDT-0.09%UNIUSD-2.58%LTCUSD-4.60%SUIUSD-1.29%HBARUSDT-0.71%TONUSD+12.52%TAOUSDT-1.17%AAVEUSD-1.24%DOTUSDT-0.94%ICPUSDT-4.04%ONDOUSDT-0.58%WLDUSDT+1.18%ARBUSDT-3.45%JUPUSDT-1.29%ATOMUSDT-0.75%INJUSDT+1.78%STXUSDT-0.18%FETUSDT-2.25%SEIUSDT-0.61%PYTHUSDT+0.86%TIAUSDT-0.59%IMXUSDT-2.28%GRTUSDT-1.04%OPUSDT-3.71%IOTAUSDT+3.66%WIFUSDT-0.40%AXSUSDT-1.32%POLUSDT-0.29%FARTCOINUSDT+1.82%EOSUSDT+4.13%DYDXUSDT-2.25%GALAUSDT-0.52%ORDIUSDT+1.95%RONINUSDT+2.94%NOTUSDT+1.29%
CZ

Carl Zeiss Meditec AG (AFXd)

FRA • Healthcare

€31.37
+€0.92 (+3.1%)
Market open

October 6, 2026 at 12:32 UTC

Open€29.4
Previous Close€30.44
Day Range€29.06 - €30.9
Avg. Volume (3M)165.2K
Market Cap€2.7B
P/E Ratio18.2
52 Week Range
€22.62€48.36

Interactive Chart

12:32:36 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned€562.7M100%
Gross Profitminus cost of goods€302.2M54%
Operating Incomeminus R&D and overhead€60.9M11%
Net Incomeminus taxes and the rest€55M10%

In plain terms: out of every €100 in revenue, Carl Zeiss Meditec AG keeps €10 as net profit.

Fundamentals & Financials

Revenue (TTM)
€2.6B
Net Income (TTM)
€116.6M
EPS (TTM)
€1.67
ROA (TTM)
0%
Current Ratio
0
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

€0.71Q2 2020
-57.9%Q3 2020€0.06

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2020
Miss -57.9%

Carl Zeiss Meditec’s third fiscal quarter of 2026 delivered a mixed read versus consensus, with EPS topping expectations while revenue trailed, as reported on August 6, 2026. Revenue rose 2.4% to about EUR 562.7 million (up from about EUR 549.6 million a year ago), but still trailed forecasts, with revenue of EUR 562.7 million against a EUR 615.3 million estimate (-8.5%). Profitability improved notably in the period, with gross margin at roughly 54% and operating margin near 11%, translating into gross profit of about EUR 302.3 million and operating income of roughly EUR 60.9 million. Net income surged 93.9% to around EUR 55.0 million, up from about EUR 28.4 million a year ago, and EPS of EUR 0.64 topped the EUR 0.39 estimate (+64.1%) while also rising 93.9% from EUR 0.33 a year ago.

View full earnings history

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG, listed on XETRA as AFX.DE, makes medical technology for eye care and surgery. In the healthcare equipment field, it sells diagnostic and therapeutic ophthalmic products and other medical instruments and supplies and, in FY2025, generated EUR 2.2 billion in revenue.

Name
Carl Zeiss Meditec AG
CEO
Andreas Pecher
Website
www.zeiss.com
Industry
Healthcare
Year Founded
1846
Employees
5,784

Today's Snapshot

AI-generated

AFXd is trading 2.8% above yesterday's close, in line with a firmer sector.

Trading Volume

Below 10d avg (149.0K)

34K

vs S&P 500 Today

Outperforming Market

+2.17%

Updated: October 6, 2026 at 10:31 UTC

Technical Indicators

5 Buy2 Neutral1 Sell
AFXd displays a modest buy bias driven largely by positive momentum and bullish short- to medium-term moving averages, while longer-term evidence is mixed. Momentum and MACD readings favor the upside, and price sits slightly above most short- and medium-term averages even as the 200-day average lies just above the current level, suggesting some longer-horizon resistance. Trend strength is muted, with a low ADX indicating a lack of a strong directional trend, while volatility is moderate and on‑balance volume is showing a constructive signal despite a negative cumulative level. Technical takeaway: Moderate buy bias supported by short-term momentum and averages.
All signals
  • EMA (5 indicators)$30.08 - $31.77
    Buy
  • RSI (14)53.47
    Neutral
  • Stochastic %K (14, 3, 3)70.52
    Neutral
  • MACD Level (12, 26)0.08
    Buy

Peers & Related Assets

BZ7A.FBumrungrad Hospital Public Company Limited
1SXP.FSCHOTT Pharma AG & Co. KGaA
FIE.DEFielmann AG
BBZA.DEBB Biotech AG
DRW8.DEDrägerwerk AG & Co. KGaA
DRW3.DEDrägerwerk AG & Co. KGaA
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.